FH Europe News

Post technical meeting statement on FH paediatric screening

Post technical meeting statement on FH paediatric screening

FH paediatric screening in the EU and the wider Europe is achievable, with the right political will, smart investment and genuine partnership that include patients and citizens as equal players. The overriding message from the high-level technical meeting on FH...

The Time is Now: Cardiovascular Disease as an EU Priority

The Time is Now: Cardiovascular Disease as an EU Priority

The Time is Now: Cardiovascular Disease as an EU Priority: achieving FH paediatric screening across Europe Fewer victims, healthier lives, at lower cost Key points, context, facts and figures on a non-communicable disease that concerns 2.5 million people in wider...

Heart Beat News – September 2021

Heart Beat News – September 2021

Read the September edition of FH Europe’s Heart Beat newsletter: In this edition: Read our Patient Stories, highlighting our courageous network of patient advocates sharing their unique stories and experiences of living with FH, HoFH, Lp(a) and FCS. Discover the...

The Global FH registry publication in the Lancet

The Global FH registry publication in the Lancet

Global FHSC registry highlights the challenges of familial hypercholesterolaemia: late detection, undertreatment, and disparities between men and women. First data from the European Atherosclerosis Society (EAS) Familial Hypercholesterolaemia Studies Collaboration...

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is registered as a charity; Charity number 1170731, registered in England and Wales.

FH Europe is supported by an educational grant from Amgen Limited, Sanofi, Regeneron, Akcea Therapeutics Inc. and Amryt
Site by: Vovi Web Design